ARCHIVES

Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds

This article is from The Cancer Letter archive.

Vol. 38 No. 15 | April 13, 2012

Download PDF Visit The Full Archive

Related Articles

ONS Meeting Again With ASCO And AACR In San Francisco

April 28, 1989

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

Heavy Smokers And Drinkers Have Different Brain Chemistry

May 30, 2003

How Much Is Life Worth? The $440 Billion Question

July 31, 2009

Virology Contract Phaseout To Cut $5 Million In FY 1980; Bigger reduction Coming In 1982

July 27, 1979

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007